Abingworth Management Ltd. · London United Kingdom
| 38 Jermyn St. | Phone: +44-207-534-1500 |
| London | Fax: +44-207-287-0480 |
| SW1Y 6DN | |
| United Kingdom | 
Map This Company |
Abingworth Management Ltd. Rankings
Company Description
Abingworth believes scientific excellence is worth investing in. The company is a venture capital firm focused on all stages of life science investments and health care businesses in Europe and the US. It typically invests from $20 million to $80 million over the life of its involvement, a span of time averaging three to eight years. Portfolio holdings include drug developers Avila Therapeutics and Dicerna Pharmaceuticals and orthopedic products maker Stanmore Implants. The company has invested in companies engaged in structural biology, neuroscience, cell biology, gene therapy, and health care services. Abingworth has about $1.25 billion under management; it has established seven funds since 1973.
Abingworth Management Ltd. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | PrivateSingle Location |
|---|---|
| Fiscal Year-End | June |
| Employees | 20 |
Executives
18 executives listed for Abingworth Management Ltd.'s London, United Kingdom location.
| Advisor, US | Herbert Heyneker | |
|---|---|---|
| Director, US | Michael Bigham | |
| Partner, UK | Genghis Lloyd-Harris |